Join to View Full Profile
865 Northern BoulevardSuite 302Great Neck, NY 11021
Phone+1 516-708-2550
Fax+1 516-708-2597
Dr. Furie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 1982 - 1984- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1979 - 1982
Weill Cornell MedicineClass of 1979
Certifications & Licensure
NY State Medical License 1980 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2014-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2014-2017
Publications & Presentations
PubMed
- Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment.Andrea Fava, Catriona A Wagner, Carla J Guthridge, Susan Macwana, Wade DeJager
Arthritis Care & Research. 2026-04-01 - Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus.Richard A Furie, Maria Dall'Era, Edward M Vital, Jay P Garg, Fedra Irazoque Palazuelos
The New England Journal of Medicine. 2026-03-06 - Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS).Eric F Morand, Richard Furie, Martin Aringer, Laurent Arnaud, Christine Peschken
Rheumatology. 2026-02-04
Journal Articles
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus NephritisRichard Furie, Brad H Rovin, The New England Journal of Medicine
Lectures
- 6th Annual Perspectives in Rheumatic DiseasesGlobal Academy for Medical Education (Elsevier), Las Vegas, Nevada - 9/20/2013
- Advances in B Cell Biology: Rheumatoid Arthritis, Systemic Lupus Erythematosus, & VasculitisCleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Scottsdale, Arizona - 2/18/2012
Press Mentions
FDA Approves Third-Ever Drug for Lupus NephritisOctober 20th, 2025- Efgartigimod Use Extends to Myositis and Sjögren Disease in Phase 2 TrialsJune 30th, 2025
- New Data at EULAR Signal Advances in RA, Myopathy, GoutJune 27th, 2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
